Researchers should monitor: Eli Lilly investor relations page for trial result announcements ClinicalTrials.gov for individual trial status updates FDA announcements for any regulatory interactions Medical conferences (ADA, ObesityWeek, EASD) where data may be presented SeekPeptides provides ongoing coverage of retatrutide developments, including dosing guides , availability updates , and comparison analyses that help researchers stay current with the latest information
Seek urgent medical attention for severe abdominal pain, persistent vomiting, visual changes, or signs of allergic reaction
If youre currently taking a monoamine oxidase inhibitor (MAOI) or have taken an MAOI, like linezolid or intravenous methylene blue, within the last 2 weeks, dont start taking Lexapro without the guidance of a healthcare provider
The article's table puts constipation at 20 to 30 percent for semaglutide and 25 to 35 percent for tirzepatide, and suggests the dual GIP and GLP-1 action may raise the risk through its effects on gut motility
doi: 10.1016/j.bbacli.2016.02.001, 138